Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual fitness for aging hearts: a new frontier in cardiac rehab?

NCT ID NCT05972850

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Sep 11, 2026 · Updated 2 times

Summary

This pilot study is testing a home-based virtual exercise program called Vivo Heart for older adults with cardiovascular disease. The program involves live, small-group sessions led by certified trainers, combining physical exercises with cognitive challenges to improve strength, balance, and thinking. The goal is to see if this approach is feasible and acceptable for rural older adults, and to gather early data on its effects on fitness, quality of life, and other health measures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vivo Heart, a home-based virtual exercise program with dual-tasked cognitive-motor exercises, delivered live by certified trainers in small groups.
What this could lead to
If successful, this program could offer a practical way for older adults with heart disease to improve their physical and mental fitness from home, potentially reducing the need for in-person cardiac rehab.
What could go wrong
This is a small pilot study, so results may not apply to everyone. The program requires internet access and motivation, and its benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Mar 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 60 - 80 years * Lives in a rural area based on established urban-rural definitions (e.g., RUCA codes, RUCC, UIC) * A qualifying Cardio Vascular Disease (CVD) event or procedure * Cognitively unimpaired Telephone Interview for Cognitive Status (TICS-m ≥32) * No major depressive symptoms Patient Health Questionnaire (PHQ-8 \<10) * Ambulatory and community-dwelling * Less than 150 min per week of moderate-to-intensive aerobic or resistance exercise in the past month * Medically cleared for exercise if event was within the last 6 months * Access to a tablet or computer and internet/Wi-Fi in defined exercise space * Able to provide own transportation to study visits * Not participating in a clinical trial * Willing to provide informed consent Exclusion Criteria: * \<60 years or \>80 years * Lives in non-rural area * No CVD or a qualifying event or procedure * Dementia or severe cognitive impairment (TICS-m \<32) * Clinical depression (PHQ-8 ≥10) * Non-ambulatory, institutionalized, or requires walker * Regular aerobic or resistance exercise (including current participation in a cardiac rehab program) * Not medically cleared for exercise * Advanced kidney disease requiring dialysis or dialysis anticipated within 6 months * Insulin-dependent diabetes * Use of any supplemental oxygen for COPD * Significant impairment from a prior stroke * Progressive neurologic disease (Parkinson's, ALS, multiple sclerosis, Alzheimer's disease, dementia) * Severe arthritis, fracture, chronic injury, or other musculoskeletal disorder that prevents walking independently * Cancer (not including non-melanoma skin cancers) requiring treatment with the past year * Excessive alcohol consumption (\>7/week alcoholic beverages for women and \>14/week for men) in the past month * Joint replacement or other orthopedic surgery in past 12 months or planned in next 6 months * No computer, tablet or internet access * No access to transportation for travel to study visits * Current participation in a clinical trial * Inability or unwillingness to comply with the study requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.